Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction

Published:2022-01-01 Issue:1 Volume:7 Page:17
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Mann Douglas L.¹,Givertz Michael M.²,Vader Justin M.¹,Starling Randall C.³,Shah Palak⁴,McNulty Steven E.⁵,Anstrom Kevin J.⁵,Margulies Kenneth B.⁶,Kiernan Michael S.⁷,Mahr Claudius⁸,Gupta Divya⁹,Redfield Margaret M.¹⁰,Lala Anuradha¹¹,Lewis Gregory D.¹²,DeVore Adam D.⁵¹³,Desvigne-Nickens Patrice¹⁴,Hernandez Adrian F.⁵¹³,Braunwald Eugene²,Mohammed Selma F.¹⁵,Birru Hellina¹⁵,Aboye Etsubdink¹⁵,Lam Phillip H.¹⁵,Escobar Nicole¹⁵,Fink Maria¹⁵,Cappola Thomas P.¹⁵,Sheaffer Wendy¹⁵,Reilly Bonitta¹⁵,Ferree Jenny¹⁵,Ravichandran Ashwin K.¹⁵,Ciezkowski Gina¹⁵,Herrera Glenda¹⁵,Mehta Hirsch S.¹⁵,DeLucca Rosemarie¹⁵,Doddamani Sanjay¹⁵,Kanwar Manreet¹⁵,Thomas Brooke¹⁵,Machen Laurie¹⁵,Kim January¹⁵,Christina Athas¹⁵,Lampert Brent C.¹⁵,Fontenelle Cindy¹⁵,Eiswirth Clement C.¹⁵,Williams Julie¹⁵,Rock Darlene¹⁵,Egnaczyk Gregory F.¹⁵,Rentas-Sherman Enya¹⁵,Barr Deborah¹⁵,Bhimaraj Arvind¹⁵,Damato Adrianna¹⁵,Calayo Christine¹⁵,Herre John M.¹⁵,Lindenfeld Joann¹⁵,Carroll Amanda¹⁵,Gordon Mary¹⁵,Keebler Mary E.¹⁵,Setliff Bandaa¹⁵,Gulati Sanjeev K.¹⁵,Winkler Krystal¹⁵,Curtin Laura¹⁵,Ohmart Carly¹⁵,Halvorson John¹⁵,Mudd James O.¹⁵,Camacho S. Albert¹⁵,Palardy Maryse¹⁵,Shah Neha¹⁵,Picardi Kristina¹⁵,Krishnamoorthy Arun¹⁵,Maximin Adrienne¹⁵,Horstmanshof Douglas A.¹⁵,Seiler Beverly¹⁵,Xu Zi J.¹⁵,Mersola Savannah¹⁵,Kransdorf Evan P.¹⁵,Tang Wilson¹⁵,Fonk Teresa¹⁵,Gorodeski Eiran Z.¹⁵,Oliveira Guilherme H.¹⁵,Semenec Terrence¹⁵,Norton Nadine¹⁵,Nichols Julie¹⁵,Leo Peter¹⁵,Dunlap Mark E.¹⁵,Felker G. Michael¹⁵,Taylor Lacey¹⁵,Sheehan Mary¹⁵,Levine Sharon¹⁵,Cocca-Spofford Diane¹⁵,Brooks Liana¹⁵,Cunningham Thomas¹⁵,Acker Nancy¹⁵,Milbrandt Susan¹⁵,Gatzke Janet¹⁵,Davila-Roman Victor G.¹⁵,Dirks Anne¹⁵,Bult Karen¹⁵,Weber Elizabeth¹⁵,Lesko Mary¹⁵,Mikhalkova Deana¹⁵,Fitzgerald Kathleen¹⁵,Whellan David J.¹⁵,Wever-Pinzon Omar¹⁵,Gutierrez Jonathan¹⁵,Goldsborough Yavette¹⁵,Gilotra Nisha A.¹⁵,Caikauskaite Indre¹⁵,Skopicki Hal A.¹⁵,Huggins Gordon S.¹⁵,Yuen Nathan¹⁵,Haynes Abbey¹⁵,Katie Carr¹⁵,Snell Gail¹⁵,Smith Andrew L.¹⁵,Walker Brandon¹⁵,Johnson Jovita¹⁵,Henderson Simmone¹⁵,Pauwaa Sunil¹⁵,Bhat Geetha¹⁵,Gagliardi Ann¹⁵,

Affiliation:

1. Department of Medicine, Washington University in St Louis, St Louis, Missouri

2. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

3. Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio

4. Inova Heart and Vascular Institute, Falls Church, Virginia

5. Duke Clinical Research Institute, Duke University, Durham, North Carolina

6. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia

7. Department of Medicine, Tufts Medical Center, Boston, Massachusetts

8. Department of Medicine, University of Washington, Seattle

9. Department of Medicine, Emory University, Atlanta, Georgia

10. Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota

11. Icahn School of Medicine at Mount Sinai, New York, New York

12. Department of Medicine, Massachusetts General Hospital, Boston

13. Department of Medicine, Duke University, Durham, North Carolina

14. Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Baltimore, Maryland

15. for the LIFE Investigators

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2785700/jamacardiology_mann_2021_oi_210073_1640293621.08297.pdf

Reference17 articles.

1. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.;Yancy;Circulation,2013

2. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America.;Yancy;J Am Coll Cardiol,2016

3. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC.;Ponikowski;Eur Heart J,2016

4. Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) registry.;Ambardekar;J Heart Lung Transplant,2019

5. Angiotensin-neprilysin inhibition versus enalapril in heart failure.;McMurray;N Engl J Med,2014

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction;Current Problems in Cardiology;2024-11

2. Pharmacological and Device-Based Intervention for Preventing Heart Failure After Acute Myocardial Infarction　― A Clinical Review ―;Circulation Journal;2024-09-13

3. Effect of ARNI (Sacubitril/Valsartan) and SGLT2 Inhibitors (Dapagliflozin) either alone or in Combination on Heart Failure: An Exploration of Novelty;Journal of Young Pharmacists;2024-08-23

4. Waiting list and post-transplant outcome in Sweden after national centralization of heart transplant surgery;The Journal of Heart and Lung Transplantation;2024-08

5. The function and therapeutic potential of transfer RNA-derived small RNAs in cardiovascular diseases: A review;Pharmacological Research;2024-08